Semaglutide has transformed the landscape of weight loss medicine in the United States. Originally developed to treat type 2 diabetes under the brand name Ozempic, semaglutide was approved by the FDA for chronic weight management under the brand name Wegovy in 2021. Since then, it has become one of the most prescribed weight loss medications in America — and for good reason.
1What Is Semaglutide and How Does It Work?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is a hormone naturally produced in your gut after eating. It signals the brain that you're full, slows gastric emptying, and regulates blood sugar. Semaglutide mimics this hormone, but with one crucial difference: it has a much longer half-life, meaning a single weekly injection can maintain these effects around the clock.
At the higher dose used in Wegovy (2.4mg weekly), the effects on appetite suppression and weight loss are significantly more pronounced than at the diabetes dose used in Ozempic. This isn't simply "willpower in a syringe" — it's pharmacological correction of hunger signals that are dysregulated in obesity.
2Clinical Trial Results: What the Evidence Says
The landmark STEP 1 trial, published in the New England Journal of Medicine, enrolled 1,961 adults with obesity. At 68 weeks, participants receiving semaglutide 2.4mg lost an average of 14.9% of their body weight compared to 2.4% in the placebo group. When analyzed among those who completed the full course, average weight loss exceeded 17%. In real-world settings, many patients achieve 15–21% body weight reduction.
The STEP 2 trial examined patients with type 2 diabetes and found 9.6% weight loss. The STEP 4 trial demonstrated that stopping semaglutide leads to weight regain — confirming that the medication works best as an ongoing treatment rather than a short-term fix.
3Who Qualifies for Semaglutide in the USA?
FDA approval for Wegovy covers adults with a BMI of 30 or higher (obesity), or a BMI of 27 or higher (overweight) with at least one weight-related comorbidity such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea.
During your online consultation with a licensed US physician, they will review your BMI, medical history, current medications, and any contraindications. Semaglutide is not appropriate for patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or those who are pregnant or planning pregnancy.
4Side Effects and How to Manage Them
The most common side effects are gastrointestinal: nausea (reported in 44% of patients), vomiting, diarrhea, and constipation. These effects are most pronounced during dose escalation — which is why Wegovy follows a structured ramp-up schedule starting at 0.25mg weekly and gradually increasing over 16-20 weeks to the full 2.4mg dose.
Most patients find nausea significantly improves after the first 4-8 weeks. Practical strategies include eating smaller meals, avoiding high-fat or spicy foods, and injecting at bedtime. Serious side effects, including pancreatitis and gallbladder issues, are rare but warrant immediate medical attention.
5How to Get Semaglutide Online in the USA
Through Weight Loss Solutions, getting a semaglutide prescription is straightforward. You complete a detailed online health questionnaire covering your medical history, current medications, and weight loss goals. A licensed US physician reviews your submission within 24 hours. If appropriate, they issue a prescription that is sent electronically to our NABP-accredited partner pharmacy.
Your medication is shipped in temperature-controlled packaging within 24-48 hours of approval. Wegovy pens are pre-filled and easy to self-administer — most patients find the process less daunting than expected. Your provider will check in at regular intervals to monitor progress and adjust your plan as needed.
This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any weight loss medication. Individual results may vary.